highly significantp < 0.001
Ceftriaxone, ceftazidime, linezolid, meropenem, tigecycline, vancomycin, and tazocin were the IV antibiotics administered in the preceding 3 months and their correlation to the study group (MDRO) was highly significant ( p < 0.001) when comparing to the control group ( Table 3 ).